Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,842.40
(
0.45%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
96.44
(
1.23%
)
Bitcoin
66,837.06
(
0.23%
)
News Focus
News Focus
Post# of 828959
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ATLnsider

Send PM Follow Ignore
Followers 175
Posts 3513
Boards Moderated 1
Alias Born 11/03/2014

ATLnsider

Re: flipper44 post# 733634

Saturday, 11/23/2024 11:31:09 AM

Saturday, November 23, 2024 11:31:09 AM

Post# of 828959
Thanks flipper44. I also agree that the new formulation of DCVax-L and DCVax-Direct will include an inflammation-activating lipid.

But, in my opinion, and as outlined in the patent application you linked, the inflammation-activating lipid will be used in addition to the maturation and immune-boosting agent.

All of these together, will hyperactivate the dendritic cells in both DCVax-L and DCVax-Direct.
Bullish
Bullish

This is a PSA to all manipulative and collusive Market Makers, Hedge Funds and Short Sellers:

TIME IS RUNNING OUT. THE CLOCK IS TICKING!!!

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News